$2.57T
Total marketcap
$183.6B
Total volume
BTC 50.05%     ETH 15.87%
Dominance

Chinook Therapeutics KDNY Stock

40.39 USD {{ price }} 0.000000% {{change_pct}}%
Exchange
NasdaqGS
Market Cap
2.71B USD
LOW - HIGH [24H]
0.0000 - 0.0000 USD
VOLUME [24H]
0 USD
{{ volume }}
P/E Ratio
0
Earnings per share
0 USD

Chinook Therapeutics Price Chart

Chinook Therapeutics KDNY Financial and Trading Overview

Chinook Therapeutics stock price 40.39 USD
Previous Close 37.63 USD
Open 37.7 USD
Bid 0 USD x 800
Ask 0 USD x 1200
Day's Range 37.45 - 37.92 USD
52 Week Range 16.55 - 38.14 USD
Volume 3.08M USD
Avg. Volume 1.2M USD
Market Cap 2.53B USD
Beta (5Y Monthly) 0.351091
PE Ratio (TTM) N/A
EPS (TTM) 0 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 40.1 USD

KDNY Valuation Measures

Enterprise Value 2.22B USD
Trailing P/E N/A
Forward P/E -10.95942
PEG Ratio (5 yr expected) -1.3
Price/Sales (ttm) 481.98297
Price/Book (mrq) 6.1260533
Enterprise Value/Revenue 421.558
Enterprise Value/EBITDA -11.252

Trading Information

Chinook Therapeutics Stock Price History

Beta (5Y Monthly) 0.351091
52-Week Change 102.73%
S&P500 52-Week Change 20.43%
52 Week High 38.14 USD
52 Week Low 16.55 USD
50-Day Moving Average 23.27 USD
200-Day Moving Average 22.79 USD

KDNY Share Statistics

Avg. Volume (3 month) 1.2M USD
Avg. Daily Volume (10-Days) 3.82M USD
Shares Outstanding 67.04M
Float 55.92M
Short Ratio 4.91
% Held by Insiders 2.61%
% Held by Institutions 96.29%
Shares Short 4.17M
Short % of Float 7.27%
Short % of Shares Outstanding 6.23%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 1:5

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) -3843.62%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -23.50%
Return on Equity (ttm) -51.56%

Income Statement

Revenue (ttm) 5.26M USD
Revenue Per Share (ttm) 0.08 USD
Quarterly Revenue Growth (yoy) -32.20%
Gross Profit (ttm) -135083000 USD
EBITDA -197027008 USD
Net Income Avi to Common (ttm) -216358000 USD
Diluted EPS (ttm) -3.21
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 350.38M USD
Total Cash Per Share (mrq) 5.24 USD
Total Debt (mrq) 38.26M USD
Total Debt/Equity (mrq) 9.28 USD
Current Ratio (mrq) 7.037
Book Value Per Share (mrq) 6.172

Cash Flow Statement

Operating Cash Flow (ttm) -143427008 USD
Levered Free Cash Flow (ttm) -84437000 USD

Profile of Chinook Therapeutics

Country United States
State WA
City Seattle
Address 400 Fairview Avenue North
ZIP 98109
Phone 206 485 7241
Website https://www.chinooktx.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 214

Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. Its product candidates also include BION-1301, an anti-APRIL monoclonal antibody is being evaluated in a Phase I/II trial for IgA nephropathy; and CHK-336, an oral small molecule LDHA inhibitor for the treatment of primary hyperoxaluria, as well as research programs for other rare and severe chronic kidney diseases. Chinook Therapeutics, Inc. is headquartered in Seattle, Washington.

Q&A For Chinook Therapeutics Stock

What is a current KDNY stock price?

Chinook Therapeutics KDNY stock price today per share is 40.39 USD.

How to purchase Chinook Therapeutics stock?

You can buy KDNY shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Chinook Therapeutics?

The stock symbol or ticker of Chinook Therapeutics is KDNY.

Which industry does the Chinook Therapeutics company belong to?

The Chinook Therapeutics industry is Biotechnology.

How many shares does Chinook Therapeutics have in circulation?

The max supply of Chinook Therapeutics shares is 67.05M.

What is Chinook Therapeutics Price to Earnings Ratio (PE Ratio)?

Chinook Therapeutics PE Ratio is 0.00000000 now.

What was Chinook Therapeutics earnings per share over the trailing 12 months (TTM)?

Chinook Therapeutics EPS is 0 USD over the trailing 12 months.

Which sector does the Chinook Therapeutics company belong to?

The Chinook Therapeutics sector is Healthcare.

Chinook Therapeutics KDNY included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 16103.45 USD
+0.82
4.52B USD 16094.17 USD 16247.59 USD 4.52B USD
Nasdaq US 700 Small Cap Index NQUS700SC 2078.81 USD
-0.4
2075.76 USD 2093.28 USD
Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG 2568.29 USD
+0.16
2566.7 USD 2581.47 USD
NASDAQ Biotechnology NBI 4337.34 USD
-0.65
4335.84 USD 4376.86 USD
NASDAQ HealthCare IXHC 986.88 USD
-0.25
986.44 USD 994.67 USD
NASDAQ Global Select Market Com NQGS 7837.41 USD
+0.85
7832.7 USD 7908.95 USD
Stlmt ID NASDAQ Biotechnology NBX 4604.4 USD
-2.98
4555.41 USD 4917.8 USD